Australia markets open in 3 hours 30 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
74.96+1.16 (+1.57%)
At close: 04:00PM EDT
74.96 0.00 (0.00%)
After hours: 04:27PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close73.80
Bid74.86 x 800
Ask74.87 x 3200
Day's range74.07 - 75.51
52-week range53.22 - 80.59
Avg. volume12,105,922
Market cap160.059B
Beta (5Y monthly)0.39
PE ratio (TTM)24.90
EPS (TTM)3.01
Earnings date26 Oct 2022
Forward dividend & yield2.16 (3.00%)
Ex-dividend date30 June 2022
1y target est81.38
  • Zacks

    Clovis (CLVS) Q2 Loss Wider Than Expected, Revenues Miss

    Clovis (CLVS) incurs a wider-than-estimated loss in second-quarter 2022. Sales of the sole marketed drug Rubraca decline year over year due to COVID-19 impacts. CLVS faces the risk of a cash crunch.

  • Simply Wall St.

    Is There An Opportunity With Bristol-Myers Squibb Company's (NYSE:BMY) 48% Undervaluation?

    In this article we are going to estimate the intrinsic value of Bristol-Myers Squibb Company ( NYSE:BMY ) by taking the...

  • Motley Fool

    3 Unstoppable Stocks That Don't Care About the Bear Market

    Whether it's thanks to a winning business model or timely good news, some companies are taking the bear market in stride, and some are even crushing it. Compared to the broader market's slump of around 5% in the last 12 months, AstraZeneca's (NASDAQ: AZN) stock has climbed 19%, making it a robust outperformer, to say the least. The company's success during the bear market is simply a matter of the strength of its drug development pipeline; with 184 projects in clinical trials and late-preclinical testing, it's among the largest in the world.